Gregory P. Donoho

3.1k total citations
32 papers, 1000 citations indexed

About

Gregory P. Donoho is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gregory P. Donoho has authored 32 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gregory P. Donoho's work include DNA Repair Mechanisms (9 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cancer Genomics and Diagnostics (6 papers). Gregory P. Donoho is often cited by papers focused on DNA Repair Mechanisms (9 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cancer Genomics and Diagnostics (6 papers). Gregory P. Donoho collaborates with scholars based in United States, Austria and South Korea. Gregory P. Donoho's co-authors include Maria Jasin, Paul Berg, Paul Hasty, Masami Morimatsu, Bernard Axelrod, Janusz Steczko, Max Gassmann, P Berg, Jack E. Dixon and James C. Clemens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Gregory P. Donoho

32 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory P. Donoho United States	17	698	236	168	128	110	32	1000
Joseph Lee United States	17	1.7k 2.4×	305 1.3×	142 0.8×	144 1.1×	79 0.7×	31	1.9k
Timothy C. Humphrey United Kingdom	22	1.5k 2.1×	286 1.2×	110 0.7×	200 1.6×	90 0.8×	40	1.7k
Ye Xu United States	15	1.6k 2.3×	426 1.8×	84 0.5×	165 1.3×	78 0.7×	25	1.8k
Luciana E. Giono Argentina	20	1.2k 1.7×	368 1.6×	157 0.9×	262 2.0×	93 0.8×	27	1.5k
Sarah E. Golding United States	13	1.0k 1.5×	489 2.1×	68 0.4×	206 1.6×	104 0.9×	17	1.3k
Josée Guirouilh‐Barbat France	24	1.5k 2.1×	534 2.3×	158 0.9×	269 2.1×	75 0.7×	40	1.7k
Patrick L. Garcia United States	19	1.0k 1.5×	390 1.7×	82 0.5×	319 2.5×	68 0.6×	30	1.3k
Katarzyna Duda Poland	8	947 1.4×	204 0.9×	168 1.0×	61 0.5×	60 0.5×	20	1.2k
Ismail Hassan Ismail Canada	17	1.2k 1.8×	441 1.9×	106 0.6×	300 2.3×	143 1.3×	27	1.5k
Catherine Tang United States	12	602 0.9×	201 0.9×	80 0.5×	73 0.6×	43 0.4×	16	1.1k

Countries citing papers authored by Gregory P. Donoho

Since Specialization

Citations

This map shows the geographic impact of Gregory P. Donoho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory P. Donoho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory P. Donoho more than expected).

Fields of papers citing papers by Gregory P. Donoho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory P. Donoho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory P. Donoho. The network helps show where Gregory P. Donoho may publish in the future.

Co-authorship network of co-authors of Gregory P. Donoho

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory P. Donoho. A scholar is included among the top collaborators of Gregory P. Donoho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory P. Donoho. Gregory P. Donoho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sweeney, Christopher J., Ivor Percent, Sunil Babu, et al.. (2022). Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 28(11). 2237–2247. 31 indexed citations

Hong, David S., Kathleen N. Moore, Johanna C. Bendell, et al.. (2021). Preclinical Evaluation and Phase Ib Study of Prexasertib, a CHK1 Inhibitor, and Samotolisib (LY3023414), a Dual PI3K/mTOR Inhibitor. Clinical Cancer Research. 27(7). 1864–1874. 37 indexed citations

Vuaroqueaux, Vincent, Swee Seong Wong, Jason C. Ting, et al.. (2020). Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma. Communications Biology. 3(1). 367–367. 13 indexed citations

Bui, Hai H., P E Sanders, Diane Bodenmiller, et al.. (2018). Direct analysis of PI(3,4,5)P3 using liquid chromatography electrospray ionization tandem mass spectrometry. Analytical Biochemistry. 547. 66–76. 19 indexed citations

Novosiadly, Ruslan D., David Schaer, Nelusha Amaladas, et al.. (2018). Abstract 4549: Pemetrexed enhances anti-tumor efficacy of PD1 pathway blockade by promoting intra tumor immune response via immunogenic tumor cell death and T cell intrinsic mechanisms. Cancer Research. 78(13_Supplement). 4549–4549. 8 indexed citations

Donoho, Gregory P., Philip W. Iversen, Youyan Zhang, et al.. (2017). Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations. Clinical Cancer Research. 23(18). 5547–5560. 39 indexed citations

Smith, Michèle C., Mary M. Mader, James A. Cook, et al.. (2016). Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth. Molecular Cancer Therapeutics. 15(10). 2344–2356. 62 indexed citations

Ye, Xiang S., Fan Li, Robert D. Van Horn, et al.. (2015). A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models. Molecular Cancer Therapeutics. 14(11). 2463–2472. 29 indexed citations

Forest, Amélie, Dale L. Ludwig, Ying Wang, et al.. (2015). Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor. Molecular Cancer Research. 13(12). 1615–1626. 27 indexed citations

10.

Barnard, Darlene, Teresa F. Burke, Gregory P. Donoho, et al.. (2015). LY2603618, a selective CHK1 inhibitor, enhances the anti-tumor effect of gemcitabine in xenograft tumor models. Investigational New Drugs. 34(1). 49–60. 19 indexed citations

11.

Pratt, Susan E., Robert L. Shepard, Gregory P. Donoho, et al.. (2013). Efficacy of Low-Dose Oral Metronomic Dosing of the Prodrug of Gemcitabine, LY2334737, in Human Tumor Xenografts. Molecular Cancer Therapeutics. 12(4). 481–490. 24 indexed citations

12.

Wu, Wenjuan, Bi Chen, Kelly M. Credille, et al.. (2013). Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET. Clinical Cancer Research. 19(20). 5699–5710. 53 indexed citations

13.

Falcón, Beverly L., Julie Stewart, John A. Wijsman, et al.. (2012). High-content multiplexed tissue imaging and quantification for cancer drug discovery. Drug Discovery Today. 18(11-12). 510–522. 14 indexed citations

14.

Thobe, Megan N., Suzane L. Um, Victoria L. Peek, et al.. (2012). Abstract 2087: Detection of KRAS mutations in circulating tumor cells (CTCs) and in formalin-fixed, paraffin-embedded (FFPE) tissue using castPCR method. Cancer Research. 72(8_Supplement). 2087–2087. 1 indexed citations

15.

Donoho, Gregory P., Mark A. Brenneman, Tracy X. Cui, et al.. (2003). Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice. Genes Chromosomes and Cancer. 36(4). 317–331. 83 indexed citations

16.

Li, Jinhe, Gregory J. Fici, Chai‐An Mao, et al.. (2003). Positive and Negative Regulation of the γ-Secretase Activity by Nicastrin in a Murine Model. Journal of Biological Chemistry. 278(35). 33445–33449. 40 indexed citations

17.

Donoho, Gregory P., Maria Jasin, & Paul Berg. (1998). Analysis of Gene Targeting and Intrachromosomal Homologous Recombination Stimulated by Genomic Double-Strand Breaks in Mouse Embryonic Stem Cells. Molecular and Cellular Biology. 18(7). 4070–4078. 145 indexed citations

18.

Gassmann, Max, Gregory P. Donoho, & P Berg. (1995). Maintenance of an extrachromosomal plasmid vector in mouse embryonic stem cells.. Proceedings of the National Academy of Sciences. 92(5). 1292–1296. 72 indexed citations

19.

Steczko, Janusz, Gregory P. Donoho, James C. Clemens, Jack E. Dixon, & Bernard Axelrod. (1992). Conserved histidine residues in soybean lipoxygenase: functional consequences of their replacement. Biochemistry. 31(16). 4053–4057. 76 indexed citations

20.

Steczko, Janusz, Gregory P. Donoho, J.E. Dixon, Toshio Sugimoto, & Bernard Axelrod. (1991). Effect of ethanol and low-temperature culture on expression of soybean lipoxygenase L-1 in Escherichia coli. Protein Expression and Purification. 2(2-3). 221–227. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact